Chromosomal Microarray Analysis (CMA) a Clinical Diagnostic Tool in the Prenatal and Postnatal Settings

Area of Science:

• Genetics
• Molecular Biology
• Medical Diagnostics

Background:

• Chromosomal microarray analysis (CMA) is a high-resolution technology for detecting submicroscopic chromosomal aberrations.
• CMA identifies copy number variants (CNVs), which are implicated in various genetic disorders.
• Conventional karyotyping has limitations in detecting small-scale genetic changes.

Purpose of the Study:

• To explain the principles, capabilities, and limitations of CMA.
• To highlight the importance of CMA in diagnosing genetic disorders.
• To inform practicing physicians about the utility of CMA in clinical settings.

Main Methods:

• Utilizes microarray technology to detect DNA copy number changes.
• Achieves resolution up to 1000 times higher than conventional karyotyping.
• Analyzes genomic DNA for microdeletions and microduplications as small as 5-10Kb.

Main Results:

• CMA demonstrates high sensitivity for submicroscopic chromosomal aberrations.
• Identifies clinically significant microdeletions and duplications.
• Reveals copy number variants (CNVs) associated with neurodevelopmental disorders and congenital anomalies.

Conclusions:

• CMA is a powerful tool for detecting genetic variations.
• Understanding CMA's benefits and limitations is essential for physicians.
• CMA plays a vital role in both prenatal and postnatal genetic diagnostics.